Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria

Clinical trial NCT05916937 · RECRUITING

Trial details

NCT number: NCT05916937
Sponsor: Simon Francis Thomsen
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria Chronic Urticaria, Idiopathic

Start date: 2024-01-12
Primary completion: 2025-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.